Medically reviewed by Qin Rao, MD Pancolitis, or extensive colitis, is a form of ulcerative colitis (UC) in which ...
MK-6194 is under clinical development by Merck and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II drugs for Ulcerative Colitis have a 45% phase transition success rate ...
Lutikizumab is under clinical development by AbbVie and currently in Phase II for Crohn's Disease (Regional Enteritis).
Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...
An ostomy is a surgical procedure creating an opening, or "stoma," on the abdomen to allow waste to exit the body. This may ...